Skip to main page content
U.S. flag
See More

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;26(5):384-97.
doi: 10.1002/jcla.21539.

External evaluation of the Dimension Vista 1500® intelligent lab system

Arnaud Bruneel  1 , Monique Dehoux, Anne Barnier, Anne Boutten
Affiliations

External evaluation of the Dimension Vista 1500® intelligent lab system

Arnaud Bruneel et al. J Clin Lab Anal. 2012 Sep.

Abstract

Background: Dimension Vista® analyzer combines four technologies (photometry, nephelometry, V-LYTE® integrated multisensor potentiometry, and LOCI® chemiluminescence) into one high-throughput system.

Methods: We assessed analytical performance of assays routinely performed in our emergency laboratory according to the VALTEC protocol, and practicability.

Results: Precision was good for most parameters. Analytical domain was large and suitable for undiluted analysis in most clinical settings encountered in our hospital. Data were comparable and correlated to our routine analyzers (Roche Modular DP®, Abbott AXSYM®, Siemens Dimension® RxL, and BN ProSpec®). Performance of nephelometric and LOCI modules was excellent. Functional sensitivity of high-sensitivity C-reactive protein and cardiac troponin I were 0.165 mg/l and 0.03 ng/ml, respectively (coefficient of variation; CV < 10%). The influence of interfering substances (i.e., hemoglobin, bilirubin, or lipids) was moderate, and Dimension Vista® specifically alerted for interference according to HIL (hemolysis, icterus, lipemia) indices. Good instrument performance and full functionality (no reagent or sample carryover in the conditions evaluated, effective sample-volume detection, and clot detection) were confirmed. Simulated routine testing demonstrated excellent practicability, throughput, ease of use of software and security.

Conclusion: Performance and practicability of Dimension Vista® are highly suitable for both routine and emergency use. Since no volume detection and thus no warning is available on limited sample racks, pediatric samples require special caution to the Siemens protocol to be analyzed in secured conditions. Our experience in routine practice is also discussed, i.e., the impact of daily workload, "manual" steps resulting from dilutions and pediatric samples, maintenances, flex hydration on instrument's performance on throughput and turnaround time.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Functional sensitivities of cardiac troponin I (cTnI) and C‐reactive protein (hsCRP): within‐run for cTnI (A) and hsCRP (B) and between‐run for cTnI (C).
Figure 2
Figure 2
Influence of interfering substances: The effects of haemolysis were evaluated according to VALTEC protocol by overloading a plasma pool with increasing concentrations of red blood cell lysate‐haemoglobin. For each test, measured values were expressed as a percentage of the baseline concentration (before overloading).
Figure 3
Figure 3
Influence of interfering substances: The effects of bilirubin‐icterus (A and B) were evaluated according to VALTEC protocol by overloading a plasma pool with increasing concentrations of total bilirubin. For each test, measured values were expressed as a percentage of the baseline concentration (before overloading).
Figure 4
Figure 4
Influence of interfering substances: The effects of turbidity‐latescence, were evaluated according to VALTEC protocol by overloading a plasma pool with increasing concentrations of IntralipidTM TG. For each test, measured values were expressed as a percentage of the baseline concentration (before overloading).
See this image and copyright information in PMC

References

    1. Ullman EF, Kirakossian H, Switchenko AC, et al. Luminescent oxygen channeling assay (LOCI): Sensitive, broadly applicable homogeneous immunoassay method. Clin Chem 1996;42:1518–1526. - PubMed
    1. Vassault A, Azzedine M, Bailly M, et al. Commission for validation of methods. French society of clinical biology. Protocole de validation de techniques (Documents A‐B‐C, stade 3). Ann Biol Clin (Paris) 1986;44:679–755. - PubMed
    1. Capolaghi B, Vassault A, Grafmeyer D, Yvert J. Le protocole Valtec: Évolution du concept et du contenu. Ann Biol Clin (Paris) 1997;55:167–173.
    1. Vassault A, Grafmeyer D, de Graeve J, Cohen R, Beaudonnet A, Bienvenu J. Quality specifications and allowable standards for validation of methods used in clinical biochemistry. Ann Biol Clin (Paris) 1999;57:685–695. - PubMed
    1. Panteghini M, Pagani F, Yeo KT, et al. Evaluation of imprecision for cardiac troponin assays at low‐range concentrations. Clin Chem 2004;50:327–332. - PubMed

Publication types